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Abstract
Background: Effective pain management following total knee arthroplasty (TKA) is fundamental in achieving
positive rehabilitation outcomes. The purpose of our study was to investigate post operative pain management in
relation to short term functional mobility in an intervention group receiving concomitant use of an IV narcotic PCA
and a continuous infusion of local anaesthetic via a femoral nerve catheter (CFNC), compared to a group receiving
narcotic PCA alone. This was a preliminary study conducted to establish an appropriate design for a larger
investigative study.
Methods: A prospective design was used to measure the effect of a CFNC on post operative pain management
and functional mobility prior to hospital discharge. The amount of fentanyl used, pain and nausea scores, timed up
and go (TUG) tests and active range of knee movement (AROM) were used to compare a CFNC and supplemental
narcotic patient controlled analgesia (PCA) group (n = 27) with a PCA only group (n = 25).
Results: The CFNC group used significantly less fentanyl than the PCA only group (p < .001) but there was no
significant difference in TUG times between the two groups. There was however a significantly lower AROM
reported for both extension (p < .04) and flexion (p < .006,) in the FNC group. Women had significantly slower
TUG times (p < .005,) and there were moderate to strong positive correlations between post operative TUG times
and the preoperative TUG time (rs = .505 p < .001), the time since oral analgesia (rs = .529 p < .014), and pain
scores (rs = .328, p = .034)
Conclusions: In this small preliminary study improved TUG performance at Day 4 post op was not influenced by
the use of a CFNC but was positively correlated with male gender, preoperative performance, time elapsed since
last oral analgesia and pain score. However AROM was decreased in the CFNC group suggesting further research
on the relationship between CFNCs, local anaesthetic concentration and quadriceps strength should be
incorporated in the follow up study’s design.
Background
Effective pain management following total knee arthro-
plasty (TKA) is generally believed to be fundamental in
achieving positive rehabilitation outcomes. It has been
shown to be important for early physiotherapy and
increased mobility and has been identified as an
influential factor in successful rehabilitation and reduced
length of hospital stay [1,2]. However, a recent Danish
study challenges this belief with their finding that pain
has limited impact on functional recovery beyond the
first post-operative day [3].
There are a range of methods that have been found to
result in early effective postoperative pain control in
patients undergoing TKA. These include intravenous
(IV) patient controlled analgesia (PCA), intrathecal and
epidural analgesia, lumbar plexus blockade, periarticular
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injection of local anaesthetics, single injection and
continuous femoral nerve blockade, oral and intramus-
cular (IMI) narcotic and non narcotic analgesics [4].
Although IV narcotic PCA has been shown to be more
effective than IMI and oral narcotic analgesia, and has
the advantage of decreasing wait time for dose adminis-
tration and dependency on nursing staff, it has been
associated with significant adverse effects such as hypo-
tension, confusion, pruritis, nausea and vomiting [5], all
of which may potentially interfere with early postopera-
tive mobility. Alternatively, the concomitant use of
femoral nerve catheters (FNC) has been found to be
associated with less PCA use, lower pain scores, and a
shortened length of hospital stay [6-9] and as a result is
becoming more appealing as a form of post operative
analgesia. This popularity may not be justified in regard
to continuous femoral nerve catheters (CFNC) as a
review by the PROSPECT group (2008) concluded that
although a femoral nerve block (FNB) was recom-
mended based on evidence of reduced pain scores and
supplemental analgesia, benefits of a continuous infusion
compared to a single injection FNB may not be suffi-
cient to justify the placement of catheters on a routine
basis [10]. Further to this, a recent study has also found
that extending an overnight CFNC to four days did not
result in any increase in health related quality of life at
either seven days or 12 months despite an increase in
passive knee flexion during the infusion period [9,11].
Additionally, evidence in relation to the possible effects
of continuous femoral nerve infusion on short term
functional recovery is mixed. Two studies, one a retro-
spective pilot study [7] and the other a prospective ran-
domised study [12] reported improved outcomes in the
CFNC group in regard to increased flexion [7,12]
decreased mobility assistance requirements [7] and
decreased length of hospital stay [7]. Whereas a further
two randomised controlled studies [13,14] reported no
difference in either maximal knee flexion on post opera-
tive day (POD) 1 and 2 [13] or at discharge [14], or in
the 2 min walk test conducted on PODs 1 to 3 [13].
There was also no difference in either time to first
ambulation or length of hospital stay [14].
The purpose of our study was to investigate post
operative pain management in relation to short term
functional mobility in an intervention group receiving
concomitant use of an IV narcotic PCA and a continu-
ous infusion of local anaesthetic via a FNC, compared
to a group receiving narcotic PCA alone. This was a
preliminary study conducted to establish an appropriate
design for a larger investigative study.
The research questions for this preliminary study
were:
1. Is postoperative pain management improved in
TKA patients who have a CFNC in addition to an
intravenous narcotic PCA compared to patients whose
pain is managed with narcotic PCA alone?
2 Is there a difference in expected and experienced
levels of pain between the two comparison groups?
3. Is functional mobility at discharge improved in
patients whose post operative analgesia is managed with
concomitant use of an intravenous narcotic PCA and
CFNC compared to those patients managed with narcotic
PCA alone?
Outcome measures used in this preliminary study
included patient’s perceived pain, narcotic usage, and
short term functional mobility. Functional mobility out-
comes were measured using active range of knee move-




A quasi-experimental design was used where patients at a
regional acute care hospital in Western Australia, who
were undergoing a primary TKA, were followed prospec-
tively to the fourth day (Day 4) after their surgery. Univer-
sity and hospital ethics committees’ approvals were
obtained prior to sequential sampling of those patients
booked for a primary Press-fit TKA under the one ortho-
paedic surgeon. Recruitment of participants was underta-
ken between June and November 2008 and 64 patients
were invited to take part in the study pre-operatively,
either at the pre-admission clinic or on the surgical ward
at the time of admission. Fifty seven patients consented to
participate however five withdrew from the study post-
operatively. This resulted in a final sample number of 52,
of which 51.9% percent (n = 27) were managed by anaes-
thetist 1, who used a continuous infusion of ropivacaine
0.2% via femoral nerve catheter in conjunction with sup-
plemental IV fentanyl PCA. The remainder of the sample
which constituted the PCA only group was managed by
anaesthetist 2 who used only, either fentanyl PCA for
40.4% (n = 21) or morphine PCA for 7.7% (n = 4) of the
group. As Anaesthetists 1 and 2 operated pre-admission
clinics on alternate weeks, allocation of study participants
to either the CFNC and supplemental PCA group or the
PCA only group was not randomised, but occurred
sequentially according to the order and timing of when
booking documentation was received at the clinic.
In Anaesthetist 1’s group a FNC was inserted post
induction of anaesthesia, and prior to incision, via the
guidance of a nerve stimulator technique. A loading
dose of 20 ml 0.75% ropivacaine and 20 ml 2% ligno-
caine was administered in the recovery room prior to
commencement of continuous infusion of 0.2% ropiva-
caine. Intravenous PCA for both groups was inserted in
theatre and commenced either in recovery or on return
to the ward depending on patient demand for analgesia.
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A physiotherapist assisted all post operative patients to
stand out of bed on Day 1, the day following surgery,
and mobilisation rehabilitation began on Day 2 and was
supervised twice a day. Continuous Passive Movement
(CPM) was commenced on the evening of Day 1 and
was then supervised twice a day until discharge. Angle
of flexion for CPM was aimed at achieving 300 on Day
1, 450 on Day 2, 600 on Day 3 and 900 on Day 4.
Data collection/Instruments
Outcome measures for pain management
Post operative perceived pain was recorded during rou-
tine post operative observations by nursing staff, who
asked participants to self report their pain using a verbal
rating scale (VRS) of 0-10 where 0 = no pain and
10 = the worst pain imagined. Additionally a short ques-
tionnaire containing Likert scale questions designed to
describe the expectations and experience of the partici-
pant’s post operative pain was administered to partici-
pants on Day 4 post operatively.
Outcome measures for functional mobility
TUG tests and active range of knee movements
(AROM) were both measured preoperatively (TUG1),
at the time of recruitment, and then again post opera-
tively on Day 4 (TUG2). The TUG2 s were measured
either on the ward or in the physiotherapy department
prior to the morning rehabilitation session. The TUG
test, first described by Podsiadlo and Richardson [15]
is a simple indicator of an older adult’s functional
mobility. It involves timing how long it takes the parti-
cipant to stand up from a chair (seat height approxi-
mately 46 cm and arm height approximately 65 cm
from the ground), walk 3 metres, turn and walk back
to the chair and sit down. Results for TUG tests are
categorised as worse than average if they exceed 9.0
secs for 60-69 years, 10.2 secs for 70-79 years and 12.7
secs for 80 to 99 years [16]. TUG tests were underta-
ken pre and postoperatively by the researchers or
research assistant.
Preoperatively participants used a gait aid if this was
how they normally mobilised. Crutches were used by
7.7% (n = 4) and a Zimmer frame by 3.8% (n = 2). Post-
operatively elbow crutches were encouraged as the aid
of choice although 25% (n = 13) used a Zimmer frame
as they had not yet developed confidence using crutches.
Reliability and validity have been established previously
[15,17,18] and the inter-rater reliability for TUG test
timing between researchers in this study was measured
using pairwise correlation (r = 1.0, p < .001, n = 10).
Range of knee movement was measured by one of the
three treating physiotherapists using a universal goni-
ometer. Intra and inter-rater reliability of the goni-
ometer has been established previously using Pearson’s
intra-class correlation (ICC (1.1) = 0.99, 0.90) [19].
Demographic variables
Demographic data and data on daily CPM, pain and
nausea scores and type and doses of analgesia, local
anaesthetic and anti-emetics received were collected
from the patient’s medical record, in addition to the
number of PCA attempts by the patient versus the num-
ber of PCA delivered doses. As a wide range of anti-
emetics were prescribed by the two anaesthetists mana-
ging each group, nausea score was used as an outcome
measure of nausea and vomiting in preference to
amount of antiemetic used. Postoperative vomiting and
nausea was classified as either: none (0), mild - intermit-
tent nausea (1), moderate - dry retching (2) or, severe -
vomiting (3).
Data Analysis
Statistical analysis was conducted using Statistical Pack-
age for the Social Sciences (SPSS 17®) for Windows
(2008) [20]. Descriptive statistics were reported as mean
and standard deviation (SD) or median and interquartile
range (IQR) according to normality. As data were mixed
in regard to normality a Mann Whitney U test was used
to compare data from the FNC and PCA only groups.
Effects size were calculated as recommended by Clark-
Carter [21] and classified by Cohen’s [22] conventions
where an r = .1 can be considered a small effect size, r
= .3 a medium effect and r = .5 a large effect. Correla-
tional analyses were conducted using Spearman’s Rho
(rs) for ordinal and non-normal scale data . P values less
than 0.5 were considered significant for all data.
Results
Demographic data
The sample consisted of 44.2% (n = 23) male and 55.8%
(n = 29) female patients with more females than males
in the CFNC group (n = 17 and 10 respectively), than in
the PCA only group (n = 12 and 13 respectively). Age
was similar for both groups within the sample with a
mean of 70 ± 8.6 years for the CFNC group and 70 ±
7.3 years for the PCA only group, as was body mass
index, (29 ± 5.5 for the CFNC group and 30 ± 3.9 for
the PCA only group). A right TKA was performed for
61.5% (n = 32) of participants, and a left TKA for 38.5%
(n = 20) with similar representation in the CFNC group
(left = 10, right = 17) and the PCA only group (left =
10, right = 15). Mean degrees of flexion reached using
CPM for each post operative day was not significantly
different for either group (Table 1) and there was no
significant difference in average length of stay which
was 6.0 ± 1.46 nights for the CFNC group and 6.0 ±
0.68 nights for the PCA only group. Patients in the
CFNC group received a mean total dose of 354 ± 71 mL
of ropivacaine 0.2% over a mean duration of 36 ± 5.8
hours at an average hourly dose of 10 ± 2.4 mL.
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Narcotic analgesia and pain scores
There was no significant difference in the duration of
PCA in the CFNC and PCA only groups (Table 2) and
the amount of intravenous fentanyl used by both groups
was compared. There was significantly more total and
daily fentanyl used in the PCA only group compared to
the CFNC group. This was also true for fentanyl used/
BMI. There were also significantly more dose increases
required on the day of surgery in the PCA only group
(Table 2).
The percentage of pain scores above 3, nausea scores
above 0 and the highest reported pain scores on Day 2
were higher in the PCA only group although the differ-
ence was not significant. However the highest reported
pain scores on both Day 0 (day of surgery) and Day 1
(day after surgery) were significantly higher (Table 3).
Pain expectations
The pain experienced by patients was either more, or a
lot more, than expected in 48.1% (n = 25) of the sample
however there was no significant difference (U = 266, z
= -.219, p < .826) in the degree of perceived pain in
relation to expectations between the CFNC and the
PCA only groups.
Functional mobility
There was no significant difference in the type of gait
aid used for either the CFNC or the PCA only group
either pre- or postoperatively or in the preoperative
TUG scores which were 12.5 ± 4.4 secs for the FNC
group and 12.3 ± 3.7 for the PCA only group. Although
the CFNC group had quicker postoperative TUG times
the difference did not reach significance for this sample
(Table 4) however there was significantly lower range of
movement reported for both extension and flexion for
the FNC group. There was no significant gender influ-
ence on AROM for either group (Table 5).
In the sample as a whole, men had quicker preopera-
tive (U = 212.5, z = -1.91, p < .056, medium effect size,
r = .30) and postoperative TUG times (U = 123,
z = -2.78, p < .005, medium effect size, r = .42) than the
women (Table 5). Men in the FNC group were also sig-
nificantly quicker (U = 28, z = -2.04, p < .042, small
effect size, r = .28) and approached significance for the
PCA only group (U = 31, z = -1.91, p < .056, small
effect size, r = .26).
There were moderate to strong positive correlations
between postoperative TUG (TUG2) scores and preo-
perative TUG (TUG1) scores (rs = .505 p < .001) and
the pain scores measured prior to TUG2 (rs = .328,
p = .034), i.e. the faster the pre-op TUG time the better
the patients performed post operatively; and the higher
their pain score just prior to undertaking TUG2 the
slower they performed. Additionally, the time lag since
last pain medication prior to performing TUG2 was sig-
nificantly higher for the FNC group (Table 4). This is
reflected in a strong positive correlation (rs = .529
p < .014) in the FNC group between time since last
medication and TUG2 scores and a strong negative
Table 1 Comparison of post operative flexion (mean ±
SD) attained using CPM for the FNC and PCA only
groups
Day post op FNC and PCA group PCA only
Day 1 Flexion (degrees) 30.3 ± 7.5 29.4 ± 7.7
Day 2 Flexion (degrees) 43.8 ± 10.4 46.3 ± 7.1
Day 3 Flexion (degrees) 66.2 ± 6.9 67.1 ± 7.8
Day 4 Flexion (degrees) 83.3 ± 7.3 80.2 ± 6.8
Table 2 Comparison of fentanyl PCA data for patients with and without a FNC
FNC group (n = 27) PCA only group (n = 21) Statistical significance
PCA duration (hours) *37.7 ± 2.8 39.6 ± 4.4 NS
Total fentanyl used (μg) Day 0 450 (220, 73) 820 (609, 1165) p < .001
Effect size medium, r = .48
Total fentanyl used (μg) Day 1 1120 (460, 1560) 1388 (1080, 2329) p < .067
Effect size small, r = .23
Total fentanyl used (μg) Day 2 180 (120, 295) 237 (188, 496) p < .03
Effect size medium, r = .31
Total fentanyl (μg) used 1860 (800, 2556) 2820 (2356, 4238) p < .001
Effect size large, r = .52
Fentanyl used (μg)/hour 51.8 (22.8, 66.8) 89 (61, 104) p < .001
Effect size large, r = .52
Fentanyl dose (μg)/BMI 53.6 (31.6, 93.8) 101 (71,129) p < .002
Effect size medium, r = .45
Mean number of dose increases required on Day 0 0 (0, 1) 1 (0,1) p < .016
Effect size medium, r = .35
% successful PCA attempts (Day 0) 75 (49, 89) 75.3 (58.3, 91.8) NS
% successful PCA attempts (Day 1) 81.3 (62.8, 92.5) 83.6 (63.2, 89.4) NS
*Mean ± SD, or median (IQR: 25,75), reported according to normality
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correlation (rs = -.505 p < .023) for the no FNC group
(i.e. the lower the time lag between analgesia and per-
forming TUG2 the better they did). However there was
no such correlation between range of movement and
time since last pain medication for either group (FNC
group, Extension: rs = -.01 p = .969, Flexion: rs = .098,
p = .69; the no FNC group, Flexion: rs= -.089 p = .745,
Extension: rs = -.084, p = .749).
Discussion
Femoral nerve catheters are now used more frequently
following TKA due to their improved efficacy in relation
to lower pain scores, and an associated decrease in nar-
cotic use post operatively. The benefits afforded by
improved pain management related to the use of
CFNCs, may also extend to benefits in short term func-
tional recovery [7-9,23] and this study has sought to
contribute further knowledge in this area by investigat-
ing the relationship between the use of a CFNC and
patient recovery in terms of their pain management, and
functional mobility prior to discharge from hospital.
Both the CFNC and the PCA only groups compared in
this study had similar characteristics in regard to age,
body mass index, operation site, length of hospital stay
and whether a gait aid was used pre-operatively. There
were also no significant differences in either the type of
gait aid used postoperatively or in flexion attained when
performing CPM exercises, whilst in hospital. Intrave-
nous narcotic PCA was available to patients in both
groups for a similar duration and both groups appeared
to have a similar understanding of how to use PCA, as
evidenced by comparable percentages of successful PCA
dose attempts delivered. However there was a higher
representation of women in the CFNC group than in
the PCA only group.
This study’s results have supported previous findings
that patients with a CFNC use less supplemental narco-
tic analgesia during the postoperative period [6,24,25].
Having a CFNC in situ had a significantly large effect
on the total fentanyl used with lower doses used, not
only on the day of operation, but also on the first and
second days postoperatively. The amount of fentanyl
used also remained significantly lower when BMI was
taken into account (Table 2). In general, patients in
both groups appeared to manage their pain appropri-
ately with an average pain score below 4 for both
groups, however the highest pain score reported by
patients was significantly higher (medium effect size) in
the PCA only group on both the day of, and the day
after, the operation. Although nausea scores were higher
in the PCA only group, the difference did not reach sig-
nificance in this sample and this is comparable with
findings from previous studies [6,24,26].
Short term functional mobility was measured using a
TUG test and AROM on Day 4 following surgery,
which was the day prior to assessment for hospital dis-
charge on the clinical pathway. In a study that examined
physical performance measures after TKA [18] the TUG
Table 3 Comparison of post operative pain and nausea and vomiting scores
Post operative pain and nausea scores FNC group (n = 27) PCA only group (n = 21) Statistical significance
Average pain score (VRS) 3.8 (2.6, 4.6) 3.4 (2.7, 4.8) NS
% pain scores above 3 45.3 ± 24.3* 48.5 ± 25.9 NS
Day 0 highest reported pain score 7.2 ± 1.7 8.36 ± 1.7 p < .017 Effect size medium, r = .35
Day 1 highest reported pain score 6 (6,7) 8 (6,9) p < .034 Effect size medium, r = .31
Day 2 highest reported pain score 3.6 ± 2.1 4.3 ± 2.8 NS
% PONV scores above 0 ** 3.3 (3,12.5) 6.4 (0,14) NS
*Mean ± SD, or median (IQR: 25,75), reported according to normality.
**Postoperative nausea and vomiting (PONV) was classified as either: none (0), mild - intermittent nausea (1), moderate - dry retching (2) or, severe - vomiting (3).
Table 4 Comparison of Day 4 Range of Movement, TUG and pain scores prior to TUG, for patients with and
without a FNC
Functional mobility, Day 4 post operatively FNC (n = 27) PCA only (n = 25) Statistical significance
AROM Flexion Day 4 (degrees) 70.8 ± 17.3* 82.6 ± 15.8 p < .006
Effect size medium, r = .38
AROM Extension Day 4 (degrees) -11.9 ± 7.0 - 8.38 ± 4.4 p < .040
Effect size small, r = .29
TUG test post op (secs) 45.23 (31, 67) 58.0 (39.5, 71) NS (outliers removed)
Pain score at TUG test 4.69 ± 2.3 3.67 ± 2.5 NS
Time elapsed since last analgesia at TUG test (hours) *3.6 ± 1.6 2.0 ± 1.1 p < .003
Effect size medium r = .42
*Mean ± SD, or median (IQR: 25,75), reported according to normality.
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test was found to be useful in the early recovery period
between one and nine to ten weeks postoperatively, by
which time the test had reached a ceiling effect where
most patients had met the 10 second criteria for being
functionally independent [15]. Preoperative TUG results
in our preliminary study indicate a degree of disability
prior to surgery with the sample averaging a time of
12.4 seconds. This was greater for women, who had
slower TUG times and supports previous research that
found gender differences exist, with women reporting
greater disability at the time of arthroplasty and lower
self-reported function [18,27,28]. This may be explained
by a study that found that women undergo arthroplasty
at a more advanced disease state than men and also, as
a result, had reduced muscle activation and increased
atrophy preoperatively [27]. This level of disability was
also reflected for women in our study’s post operative
TUG scores with women again having significantly
slower times than men. It should also be noted that the
researchers subjectively observed the men to be very
competitive when completing their TUG tests, often
asking the researchers how they compared to others and
then “swapping results” on return to their shared rooms.
Despite the gender influence, and the higher proportion
of women in the FNC group, median TUG times were
quicker for the FNC group (45 secs) than the PCA only
group (58 secs), although the difference was not signifi-
cant for this sample.
In comparison, the AROM was significantly lower in
the CFNC group than in the PCA only group. Support
for this finding is mixed. These results are not sup-
ported by previous findings from studies by Kadic et al.
[12] and DeRuyter et al. [7] who found increased flexion
on Days 3 to 6, and at Day 1 and discharge, respectively,
in patients with a CFNC in situ for 48 hours. However a
study by Carli et al. [13] using only a slightly lower dose
regimen of 8 ml/h, compared to the10 ml/h of 0.2%
ropivacaine in this study, found no significant difference
in knee flexion on Days 1 and 2. The results in our
study were not explained by the significant difference in
the time analgesia was administered prior to testing, or
by gender differences in each group. Most likely they
can be explained by studies that found that quadriceps
strength is the strongest predictor of functional perfor-
mance [29,30]. This is a matter for concern in regard to
short term functional mobility considering the recent
published caution that femoral nerve blockade may
result in prolonged quadriceps weakness and an
increased risk of falls [31]. The variance in our results
compared to the short term improvements seen in the
study by Kadic et al. [12] may be related to a reduced
dose of ropivacaine received by participants in their
study. They described a dose of between 5 and 10 ml/h
of 0.2% ropivacaine for the first 48 h (as opposed to an
average dose of 10 ml/h in this study) although there
were no details of the mean hourly or total dose
received by participants making comparisons between
the studies difficult. However recent data on the mini-
mum local anaesthetic concentration (MLAC) showed
that the minimum concentration at which patients did
not require rescue analgesia using levobupivicaine was
0.024% for the femoral nerve and 0.014% for the sciatic
nerve [32]. Even with this ultra-low concentration,
which equates to a reduction in the commercial pre-
paration’s concentration of four to six fold, there was
mild motor block manifested by an inability to dorsiflex,
which prevented early mobilisation. This may indicate
that the doses of ropivicane used in this study are
related to the significantly lower AROM observed. How-
ever this may not be significant in terms of long term
recovery as Kadic et al. also observed that short term
improvements in knee flexion did not correlate with
increased knee flexion and improved functional out-
comes at three months.
The preoperative decline of quadriceps’ strength and
function has been shown to impact negatively on func-
tional recovery [33,34] and may also explain our findings
of a strong positive correlation between slower preo-
perative TUG times and poorer postoperative TUG per-
formance. However the correlations between slower
TUG times and an increased time between analgesia
and exercise, and a higher pain score, also reinforces the
importance of timely effective analgesia prior to under-
taking exercise in the post operative period prior to dis-
charge. Our findings suggest that oral analgesia prior to
exercise, once the femoral nerve catheter has been
Table 5 Median (IQR) pre and post operative TUG test results (secs) and mean (SD) AROM (degrees) according to
gender
FNC group PCA only group
Male Female Male Female
Pre-op TUG (secs) 9.9 (9, 11.2) 13 (10, 14.1) 10.3 (9.4, 15.6) 11.5 (9.6,16.1)
Post-op TUG 2 (secs) 34 (30.9, 47.3) 60.7 (44.6, 97.5) 46.2 (34.5, 64.8) 68.5 (50, 79.6)
Post-op Flexion *72.4 ± 11.9 71.5 ± 20.3 83.1 ± 15.3 82.1 ± 16.9
Post-op Extension -11.6 ± 7.9 -12.2 ± 6.5 -8.5 ± 4.2 -8.27 ± 4.7
*Mean ± SD, or median (IQR: 25,75), reported according to normality.
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removed, is influential in improved functional mobility
although this is at odds with recent findings from Den-
mark that pain has limited impact on functional recov-
ery past the first postoperative day [3].
Positive impact on functional recovery may also be
achieved through earlier surgical intervention to prevent
severe disability prior to surgery [34-36]. However, TKA
is often delayed by either wait lists or the requirement
to decrease the need for future revision arthroplasty. In
these cases improved preoperative function through the
use of physical therapies has been shown to be effective
in improving postoperative function [37].
Study limitations and considerations for the follow-up
study
As a preliminary study this design was limited by the
lack of probability sampling and small sample number.
Subsequently there was a difference in gender represen-
tation with the increased proportion of females in the
CFNC group being more representative of the general
population, than in the PCA only group. This empha-
sises the importance of conducting a randomised design
with an a priori power analysis in the follow-up study.
Despite the absence of these design features in this pre-
liminary study, the comparison groups were similar in
their characteristics and the study was conducted pro-
spectively with differences between groups identified as
having medium to large effect sizes, so enabling impor-
tant information for the conduct of the follow up study.
Conclusions
This study found that a CFNC was associated with
important short term pain management benefits whilst
insitu, in terms of significantly less supplemental narco-
tic use, and a lower number of narcotic PCA dose
increases. Although the average pain score was not sig-
nificantly different for the CFNC and PCA only groups
the highest reported pain score was higher in the PCA
only group on both the day of, and the day after the
operation. The similar average pain scores reported in
both groups is probably indicative that patients managed
their pain appropriately with the assistance of rescue
PCA, and that the CFNC patients required significantly
less supplemental IV narcotic to achieve this. However
the benefits observed for the CFNC whilst in situ, did
not appear to extend to improved functional mobility
after its removal. Three factors associated with reduced
functional mobility on Day 4 post operatively were iden-
tified in this preliminary study. They were: gender, with
women demonstrating slower TUG times; an increased
time since oral analgesia was administered prior to
mobilisation, which also accompanied a higher pain
score; and a higher level of preoperative disability. This
reinforces previous research that suggests there are
several important factors that influence the short term
post operative functional recovery after TKA. These
include timely and effective analgesia prior to postopera-
tive exercise and either timely surgery before marked
muscle deactivation and atrophy occurs, or alternatively
improving function prior to surgery using physical ther-
apy. Of concern was the finding that AROM was signifi-
cantly decreased in the CFNC group. This indicates that
CFNC may be a variable of influence in the short term
post-operative functional mobility of patients, especially
in regard to concentrations of local anaesthetics used
and its effects on quadriceps strength, and is therefore
an important consideration in the follow up research.
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